Increasing Access to Innovative Medicines
Written Submission for the Pre-Budget Consultations in Advance of the 2026-2027 New Brunswick Budget
All Resources
Access a curated library of reports, policy submissions, data insights, and other materials informing Canada’s life sciences ecosystem.
Filter by
Increasing Access to Innovative Medicines
Written Submission for the Pre-Budget Consultations in Advance of the 2026 Newfoundland and Labrador Budget
Pre-Budget Submission 2026
Innovative Medicines Canada (IMC) is pleased to contribute to the Quebec government’s consultations on its 2026-27 budget. Availability of and […]
Increasing Access to Innovative Medicines
Written Submission for the Pre-Budget Consultations in Advance of the 2026 Ontario Budget January 2026
Increasing Access to Innovative Medicines
Written Submission for the Pre-Budget Consultations in Advance of the 2026 Alberta Budget
Increasing Access to Innovative Medicines
Written Submission for the Pre-Budget Consultations in Advance of the 2026 Nova Scotia Budget
2025 COST DRIVERS REPORT
The private drug insurance market in Canada saw a 7.3% total cost growth in 2023-2024, primarily driven by increased utilization which accounted for 60% of total cost growth. The number of claimants rose by 3.5%, with claimants making
0.9% more claims.
Increasing Access to Innovative Medicines
Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget
